• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Re-establishing Macro Vascular Flow and Wound Healing: Beyond the Vascular Intervention

  • Fri, 9/5/08 - 3:36pm
  • 0 Comments
  • 4489 reads
Author(s): 

1William J. Ennis, DO, MBA, 2Martin Borhani, MD, 3Patricio Meneses, PhD

Introduction

Since approximately 70% of wounds treated at outpatient wound centers in the United States are lower extremity venous ulcerations, we will use a leg ulcer as case study for the purposes of this article. A 65-year-old Caucasian female presents to the wound center with a 10 x 8 cm wound just above the medial malleoli. The wound has been present for 2 years and is slowly increasing in size. The skin surrounding the wound is hyperpigmented and the soft tissue is firm on palpation. The ankle circumference is 16 cm, while the mid-calf circumference is 35 cm giving the leg an “inverted champagne bottle” appearance. The wound bed is 80% yellow with a thick adherent slough noted (Figure 1). The edges of the wound are rolled over and there is no evidence of epithelial migration. The patient complains of pain that is worse at night and she develops calf pain within a 2 block ambulation distance that is relieved by standing for 5 minutes. The patient in this case suffers from a “mixed” venous/arterial ulcer, further complicating her care. A wound care work-up consists of a comprehensive history, physical exam, and a series of laboratory tests in order to arrive at a provisional diagnosis.2 As part of this work-up, the wound bed must be assessed, measured, photographed, and oftentimes, biopsied.
Much has been written about the wound micro-environment and the impact it has on healing.3 Important issues that will be discussed in this paper include the role of bacteria, inflammation, cellular proliferation, and tissue perfusion on the microenvironment.

References: 

References

1. Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 1999;19:538–545.
2. Ennis WJ, Meneses P. Comprehensive wound assessment and treatment system. In: Falabella KR (ed). Wound Healing. Boca Raton: Taylor and Francis: Boca Raton. 2005, pp. 59–68.
3. Ennis WJ. The microenvironment. Wounds 2004;16:1s–12s.
4. Burke JF. Effects of inflammation on wound repair. J Dent Res 1971;50:296–303.
5. Robson MC. Infection in the surgical patient: An imbalance in the normal equilibrium. Clin Plast Surg 1979;6:493–503.
6. Robson MC. Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 1997;77:637–650.
7. Robson MC, Stenberg BD, Heggers JP. Wound healing alterations caused by infection. Clin Plast Surg 1990;17:485–492.
8. Field FK and Kerstein MD. Overview of wound healing in a moist environment. Am J Surg 1994;167:2S–6S.
9. Stotts NA. Determination of bacterial burden in wounds. Adv Wound Care 1995;8:suppl 46–52.
10. Wang Y, Kong F, Gilbert GL, et al. Use of a multiplex PCR-based reverse line blot (mPCR/RLB) hybridization assay for the rapid identification of bacterial pathogens. Clin Microbiol Infect 2008;14:155–160.
11. Kingsley A. The wound infection continuum and its application to clinical practice. Ostomy Wound Manage 2003;49(7A Suppl):1–7.
12. Ennis WJ, Meneses P. Wound healing at the local level: The stunned wound. Ostomy Wound Manage 2000;46(1A Suppl): 39S-48S; quiz 49S-50S.
13. Robson MC, Edstrom LE, Krizek TJ, Groskin MG. The efficacy of systemic antibiotics in the treatment of granulating wounds. J Surg Res 1974;16:299–306.
14. Jones KR, Fennie K. Factors influencing pressure ulcer healing in adults over 50: An exploratory study. J Am Med Dir Assoc 2007;8:378–387.
15. Ennis WJ, Meneses P. Clinical evaluation: Outcomes, benchmarking, introspection, and quality improvement. Ostomy Wound Manage 1996;42(10A Suppl):40S–47S.
16. Ennis WJ, Lee C, Meneses P. A biochemical approach to wound healing through the use of modalities. Clin Dermatol 2007;25:63–72.
17. Carrel A, Hartmann A. Cicatrization of wound. J Exp Med 1916;24:429–450.
18. Tenorio A, Jindrak K, Weisner M, et al. Accelerated healing in infected wounds. Surg Gynecol Obstet 1976;142:537–543.
19. Levenson SM, Kan-Gruber D, Gruber C, et al. Wound healing accelerated by Staphylococcus aureus. Arch Surg 1983;118:310–320.
20. Smith M, Enquist IF. A quantitative study of impaired healing resulting from infection. Surg Gynecol Obstet 1967;125:965–973.
21. Laato M, Lehtonen OP, Niinikoski J. Granulation tissue formation in experimental wounds inoculated with Staphylococcus aureus. Acta Chir Scand 1985;151:313–318.
22. Marks J, Harding KG, Hughes LR. Staphylococcal infection of open granulating wounds. Br J Surg 1987;74:95–97.
23. Harding K. Wound care: Putting theory into practice. Wounds 1990;2:21–32.
24. Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen 1996;4:411–420.
25. Tarnuzzer RW, Schultz GS. Biochemical analysis of acute and chronic wound environments. Wound Repair Regen 1996;4:321–325.
26. Kakagia DD, Kazakos KJ, Xarchas KC, et al., Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial. J Diabetes Complications 2007;21:387–391.
27. Dawson RA, Goberdhan NJ, Freedlander E, MacNeil S. Influence of extracellular matrix proteins on human keratinocyte attachment, proliferation and transfer to a dermal wound model. Burns 1996;22:93–100.
28. Yager DR, Nwomeh BC. The proteolytic environment of chronic wounds. Wound Repair Regen 1999;7:433–441.
29. Parks WC. Matrix metalloproteinases in repair. Wound Repair Regen 1999;7:423–432.
30. Bucalo B, Eaglstein WH, Falanga V. Inhibition of cell proliferation by chronic wound fluid. Wound Repair Regen 1993;1:181–186.
31. Raffetto JD, Mendez MV, Marien BJ, et al. Changes in cellular motility and cytoskeletal actin in fibroblasts from patients with chronic venous insufficiency and in neonatal fibroblasts in the presence of chronic wound fluid. J Vasc Surg 2001;33:1233–1241.
32. Mendez MV, Stanley A, Phillips T, et al. Fibroblasts cultured from distal lower extremities in patients with venous reflux display cellular characteristics of senescence. J Vasc Surg 1998;28:1040–1050.
33. Lerman OZ, Galiano RD, Armour M, et al. Cellular dysfunction in the diabetic fibroblast: Impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 2003;162:303–312.
34. Hastings R, Qureshi M, Verma R, et al. Telomere attrition and accumulation of senescent cells in cultured human endothelial cells. Cell Prolif 2004;37:317–324.
35. Ennis WJ, Meneses P. Vascular concepts in wound healing. In: Abela GS. (ed.) Peripheral Vascular Disease: Basic Diagnostic and Therapeutic Approaches. Philadelphia: Lippincott Williams and Wilkins. 2004, pp. 403–413.
36. Pazos-Moura CC, Moura EG, Breitenbach MM, Bouskela E. Nailfold capillaroscopy in non-insulin dependent diabetes mellitus: Blood flow velocity during rest and post-occlusive reactive hyperaemia. Clin Physiol 1990;10:451–461.
37. Bacharach JM, Rooke TW, Osmundson PJ, Gloviczki P. Predictive value of transcutaneous oxygen pressure and amputation success by use of supine and elevation measurements. J Vasc Surg 1992;15:558–563.
38. Ameli FM, Byrne P, Provan JL. Selection of amputation level and prediction of healing using transcutaneous tissue oxygen tension (PtcO2). J Cardiovasc Surg (Torino) 1989;30:220–224.
39. Vigier S, Casillas JM, Dulieu V, et al. Healing of open stump wounds after vascular below-knee amputation: Plaster cast socket with silicone sleeve versus elastic compression. Arch Phys Med Rehabil 1999;80:1327–1330.
40. Clyne CA, Ramsden WH, Chant AD, Webster JH. Oxygen tension on the skin of the gaiter area of limbs with venous disease. Br J Surg 1985;72:644–647.
41. Colin D, Loyant R, Abraham P, Saumet JL. Changes in sacral transcutaneous oxygen tension in the evaluation of different mattresses in the prevention of pressure ulcers. Adv Wound Care 1996;9:25–28.
42. Chomard D, Habault P, Ledemeney M, Haon C. Prognostic aspects of TcPO2 in iloprost treatment as an alternative to amputation. Angiology 1999;50:283–288.
43. Melillo E, Ferrari M, Balbarini A, Pedrinelli R. Transcutaneous oxygen and carbon dioxide levels with iloprost administration in diabetic critical limb ischemia. Vasc Endovascular Surg 2006;40:303–311.
44. Kernick DP, Shore AC. Characteristics of laser Doppler perfusion imaging in vitro and in vivo. Physiol Meas 2000;21:333–340.
45. Christ F, Bauer A, Brugger D. Different optical methods for clinical monitoring of the microcirculation. Eur Surg Res 2002;34:145–151.
46. Ennis WJ, Meneses P. Technologies for Assessment of wound microcirculation. In: Krasner, Sibbald, Rodeheaver (eds).Chronic Wound Care: A Clinical Source Book for Healthcare Professionals, 4th edition. Malvern, PA: HMP Communications. 2005, pp. 417–426.
47. Ubbink DT, Spincemaille GH, Reneman RS, Jacobs MJ. Prediction of imminent amputation in patients with non-reconstructible leg ischemia by means of microcirculatory investigations. J Vasc Surg 1999;30:114–121.
48. Arora S, Pomposelli F, LoGerfo FW, Veves A. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J Vasc Surg 2002;35:501–505.
49. Hillier C, Sayers RD, Watt PA, et al. Altered small artery morphology and reactivity in critical limb ischaemia. Clin Sci (Lond) 1999;96:155–163.
50. Caselli A, Latini V, Lapenna A, et al. Transcutaneous oxygen tension monitoring after successful revascularization in diabetic patients with ischaemic foot ulcers. Diabet Med 2005;22:460–465.
51. Heyndrickx GR. Early reperfusion phenomena. Semin Cardiothorac Vasc Anesth 2006;10:236–241.
52. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 1999;79:609–634.
53. Movahed MR, Butman SM. The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention. Cardiovasc Revasc Med 2008;9:56–61.
54. Abbo KM, Dooris M, Glazier S, et al. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol 1995;75:778–782.
55. Matsuo H, Watanabe S, Watanabe T, et al. Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy — a prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil. Am Heart J 2007;154:994 e1–6.
56. Sakuma T, Leong-Poi H, Fisher NG, et al. Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: The role of microthromboemboli. J Am Soc Echocardiogr 2003;16:15–21.
57. Grayburn PA, Choi J. Advances in the assessment of no-reflow after successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: Now that we can diagnose it, what do we do about it? J Am Coll Cardiol 2008;51:566–568.
58. Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: A multicenter, randomized controlled trial. Lancet 2005;366:1704–1710.
59. Morykwas MJ, Simpson J, Punger K, et al., Vacuum-assisted closure: A new method for wound control and treatment: Animal studies and basic foundation. Ann Plast Surg 1997;38:553–562.
60. Ingber DE. Cellular mechanotransduction: Putting all the pieces together again. Faseb J 2006;20:811–827.
61. Saxena V, Hwang CW, Huang S, et al. Vacuum-assisted closure: Microdeformations of wounds and cell proliferation. Plast Reconstr Surg 2004;114:1086–1096; discussion 1097–1098.
62. Bertuglia S. Increase in capillary perfusion following low-intensity ultrasound and microbubbles during postischemic reperfusion. Crit Care Med 2005;33:2061–2067.
63. Bertuglia S. Mechanisms by which low-intensity ultrasound improve tolerance to ischemia-reperfusion injury. Ultrasound Med Biol 2007;33:663–671.
64. Hightower CM, Intaglietta M. The use of diagnostic frequency continuous ultrasound to improve microcirculatory function after ischemia-reperfusion injury. Microcirculation 2007;14:571–582.
65. Ennis WJ, Valdes W, Gainer M, Meneses P. Evaluation of clinical effectiveness of MIST ultrasound therapy for the healing of chronic wounds. Adv Skin Wound Care 2006;19:437–446.
66. Chen KD, Li YS, Kim M, et al. Mechanotransduction in response to shear stress. Roles of receptor tyrosine kinases, integrins, and Shc. J Biol Chem 1999;274:18393–18400.
67. Ennis WJ. Microcirculation: The push-pull theory, in Diabetic Limb Salvage Conference, M. P., Editor. 2007: Georgetown University.
68. Coulling S. Fundamentals of pain management in wound care. Br J Nurs 2007;16:S4–6, S8, S10 passim.
69. Arrick DM, Mayhan WG. Acute infusion of nicotine impairs nNOS-dependent reactivity of cerebral arterioles via an increase in oxidative atress. J Appl Physiol 2007;103:2062–2067.
70. Pullar CE, Zhao M, Song B, Pu J, et al. Beta-adrenergic receptor agonists delay while antagonists accelerate epithelial wound healing: Evidence of an endogenous adrenergic network within the corneal epithelium. J Cell Physiol 2007;211:261–272.
71. Ubbink DT, Verhaar EE, Lie HK, Legemate DA. Effect of beta-blockers on peripheral skin microcirculation in hypertension and peripheral vascular disease. J Vasc Surg 2003;38:535–540.
72. Wollina U, Abdel-Naser MB, Mani R. A review of the microcirculation in skin in patients with chronic venous insufficiency: The problem and the evidence available for therapeutic options. Int J Low Extrem Wounds, 2006;5:169–180.

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • next ›
  • last »
image description image description

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

The SFA School of Thought Continues

Lawrence A. Garcia MD
more »

Vascular Newswire

  • Vascular Solutions Launches Reprocessing Service For Closurefast Vein Catheters
    Fri, 02/03/12 - 1:14pm
  • AMA: Halt Implementation of ICD-10
    Thu, 02/02/12 - 11:56am
  • NHS Makes GBP200 Non-Drug Hypertension Treatment Device Available on Prescription
    Wed, 02/01/12 - 11:06am
  • AngioDynamics to Acquire Navilyst Medical
    Tue, 01/31/12 - 2:48pm
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

Do you think that endostaples will soon become important tools in the hands of aortic interventionists?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications